Accessibility Menu
 

Oaktree Acquisition Corp. III Life Sciences

(NASDAQ) OACCW

Current Price$0.88
Market CapN/A
Since IPO (2024)+75%
5 YearN/A
1 Year+35%
1 Month+17%

Oaktree Acquisition Corp. III Life Sciences Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$6.93M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.16 (Low)

Price

$0.88

Volume

0

Open

$0.88

Previous Close

$0.88

Daily Range

$0.88 - $0.88

52-Week Range

$0.50 - $1.01

OACCW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oaktree Acquisition Corp. III Life Sciences

Industry

Banks

Headquarters

Los Angeles, CA 90071, US

OACCW Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-0%

Return on Assets

3%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

1.23%

Stock Overview

Market Cap

$0.00

Shares Outstanding

0

Volume

0

Avg. Volume

4.67K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$1.20M

EBITDA

$1.20M

Operating Cash Flow

$422.08K

Capital Expenditure

$0.00

Free Cash Flow

$422.08K

Cash & ST Invst.

$1.43M

Total Debt

$11.82K

Oaktree Acquisition Corp. III Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$1.79M

+29.7%

EBITDA

$255.50K

-118.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.42M

+5.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$11.82K

+0.0%

Return on Assets

3.41%

N/A

Return on Invested Capital

-0.37%

N/A

Free Cash Flow

$56.52K

N/A

Operating Cash Flow

$56.52K

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DRDBWRoman DBDR Acquisition Corp. II
$0.20-8.18%
GPATWGP-Act III Acquisition Corp.
$0.15-6.13%
LPAAWLaunch One Acquisition Corp.
$0.12-7.77%
MACIWMelar Acquisition Corp. I Warrant
$0.13+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%

Questions About OACCW

What is the current price of Oaktree Acquisition Corp. III Life Sciences?

Oaktree Acquisition Corp. III Life Sciences is trading at $0.88 per share.

What is the 52-week range for Oaktree Acquisition Corp. III Life Sciences?

Over the past 52 weeks, Oaktree Acquisition Corp. III Life Sciences has traded between $0.50 and $1.01.

How much debt does Oaktree Acquisition Corp. III Life Sciences have?

Oaktree Acquisition Corp. III Life Sciences total debt is unavailable.

How much cash does Oaktree Acquisition Corp. III Life Sciences have on hand?

Oaktree Acquisition Corp. III Life Sciences does not have cash on hand data available.

What is Oaktree Acquisition Corp. III Life Sciences’s dividend yield?

Oaktree Acquisition Corp. III Life Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.